Mizuho Securities Maintains Alector(ALEC.US) With Buy Rating
Mizuho Securities Reaffirms Their Buy Rating on Alector (ALEC)
BofA Securities Maintains Alector(ALEC.US) With Hold Rating, Maintains Target Price $9
Barclays Maintains Alector(ALEC.US) With Buy Rating, Maintains Target Price $12
Alector (ALEC) Receives a Buy From Barclays
Morgan Stanley Maintains Alector(ALEC.US) With Hold Rating, Maintains Target Price $10
Alector's AL002 Holds Potential Amidst Uncertainties: A Hold Rating Analysis
Alector Analyst Ratings
TD Cowen Maintains Alector(ALEC.US) With Buy Rating
Mizuho Securities Maintains Alector(ALEC.US) With Buy Rating, Maintains Target Price $9
Alector's Strong Outlook: Advancing Pipeline and Undervalued Stock Prompt Buy Rating
Analyst Issues Buy Rating on Alector Amid Promising Biomarker Research and Positive FDA Interactions
TD Cowen Remains a Buy on Alector (ALEC)
Alector Analyst Ratings
Goldman Sachs Maintains Alector(ALEC.US) With Sell Rating
Goldman Sachs Keeps Their Sell Rating on Alector (ALEC)
Alector Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Alector, Maintains $35 Price Target
Barclays Sticks to Their Buy Rating for Alector (ALEC)
HC Wainwright & Co. : The Alector (ALEC.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $41.00 to $35.00.